About this trial
Will Calcium-Enriched Mixture (CEM) cement pulpotomy have less postoperative pain and more clinical and radiographic success compared to Calcium Hydroxide/Iodoform (Metapex) pulpectomy when managing second primary molars with irreversible pulpitis?
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
None
Trial design
Parallel
Treatments tested in this trial
Pulpotomy using Calcium-Enriched Mixture (CEM) Cement
Procedure/Surgerypulpotomy procedure using (CEM) Cement as pulp dressing material
Pulpectomy using Calcium Hydroxide/Iodoform Paste (Metapex)
Procedure/Surgerypulpectomy procdure performed using Metapex paste as root canal filling material
Treatment groups
Trial outcomes
Primary outcomes
Postoperative Pain Intensity
Pain intensity will be evaluated using the Visual Analog Scale (VAS) of faces, rated from 0 (no pain) to 5 (severe pain). Assessment will be performed at 1, 3, 6, 9, and 12 months after treatment. Clinical success will be considered when the patient reports no pain (score = 0).
Secondary outcomes
Evaluation of Clinical Success
Clinical success will be evaluated by the absence of pain, swelling, tenderness to percussion, sinus, fistula, and pathological mobility. Clinical assessment will be performed at 1, 3, 6, 9, and 12 months postoperatively.
Evaluation of Radiographic Success
Radiographic success will be defined as the absence of widening of the periodontal ligament space, internal/external root resorption, or radiolucency in the furcation or periapical area. Radiographic failure will be recorded if any of these findings are observed.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: